MedTrace Logo

Study of a Phakic Implantable Collamer Lens (ICL)

NCT07790965 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-08-27

No results posted yet for this study

Summary

A prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

Phakic Implantable Collamer Lens (ICL)

Diffractive Trifocal Phakic ICL

Sponsors & Collaborators

  • Staar Surgical Company

    lead INDUSTRY

Principal Investigators

  • Gabriel Quesada Larez, MD · Clinica Quesada SA de CV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-11-30
Primary Completion
2027-05-31
Completion
2027-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07790965 on ClinicalTrials.gov